title: Metabolism of C3 and factor B in patients with congenital factor I deficiency.
abstract: The metabolism of complement factor B and C3 was analyzed in three previously described patients with congenital deficiency of factor I (C3b/C4b inactivator). Samples taken at steady state contained elevated levels of Ba and Bb, whereas native factor B was not detectable. Following plasma infusion in two of the patients Ba was rapidly cleared (within 8-12 hr) from the circulation and native factor B increased transiently, reaching normal levels within 22-24 hr. In parallel with the increase in Ba, factor B decreased during the following days, reaching preinfusion level after seven days. This was in contrast to a continued increase in C3 concentration, which was still within the normal range 15 days after infusion, despite the presence of only trace amounts of native B. In vitro complement activation experiments, employing purified C3Nef IgG as alternative pathway activator and aggregated IgG as classical pathway activator, were performed on selected serum samples (base-line, 12 hr and 15 days postinfusion samples) from the plasma infusion series. It was demonstrated that (a) C3Nef could not induce alternative pathway C3-conversion in factor B depleted samples and (b) C3-degradation by CP-activation could still occur in B-depleted samples, although at a much slower rate compared to normal human serum. These results may partly explain the difference in kinetics of factor B and C3 metabolism seen after plasma infusion in patients with factor I deficiency.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Institute of Medical Microbiology, Odense University, Denmark.
authors.forename: J M
authors.initials: JM
authors.lastname: Rasmussen
authors.forename: B
authors.initials: B
authors.lastname: Teisner
authors.forename: J
authors.initials: J
authors.lastname: Brandt
authors.forename: I
authors.initials: I
authors.lastname: Brandslund
authors.forename: H
authors.initials: H
authors.lastname: Gry
mesh_terms: D001323:Autoantibodies / Q000032:analysis* / Q000276:immunology; D015153:Blotting, Western; D003167:Complement Activation; D003176:Complement C3 / Q000378:metabolism*; D003180:Complement C3b Inactivator Proteins / Q000172:deficiency*; D011415:Complement Factor B / Q000276:immunology / Q000378:metabolism*; D017244:Complement Factor I; D006801:Humans; D007122:Immunoelectrophoresis; D007074:Immunoglobulin G / Q000032:analysis* / Q000276:immunology; D007153:Immunologic Deficiency Syndromes / Q000097:blood* / Q000151:congenital / Q000276:immunology; D012697:Serine Endopeptidases / Q000172:deficiency*
chemical_list: D001323:Autoantibodies; D003176:Complement C3; D003180:Complement C3b Inactivator Proteins; D007074:Immunoglobulin G; D012697:Serine Endopeptidases; D017244:Complement Factor I; D011415:Complement Factor B